Khalid Satary, the owner of several labs in Georgia, Oklahoma and Louisiana, is a wanted fugitive for alleged fraud involving unnecessary cancer genetic testing that resulted in billing Medicare for over $547 million, according to HHS' Office of Inspector General.
The labs involved included Performance Laboratories in Oklahoma, Lazarus Services in Louisiana and Clio Labs in Georgia, OIG said.
Mr. Satary was charged based on his role in an alleged scheme to solicit the tests from Medicare enrollees through telemarketing and "health fairs." The tests were then approved by telemedicine doctors who did not engage in treatment.
After failing to appear at a Dec. 12, 2022, court date, Mr. Satary was declared a fugitive of justice and is currently believed to be in Dubai.